$112.90
0.620.55%
Pre-Market: 5:18 AM EDT
15 minutes delayed
Comments
Loading...
BioNTech (BNTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestBioNTech (NASDAQ:BNTX) Stock Quotes, Forecast and News Summary
BioNTech Stock (NASDAQ: BNTX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 747.00 / 936.45K |
| Day Range | - - - |
| 52 Wk Range | 76.53 - 131.49 |
| Market Cap | $27.21B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 66 |
| Short Interest | 5.04% |
| Days to Cover | 4.11 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About BioNTech SE
Sector
Health Care
Industry
Biotechnology
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, in...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioNTech (BNTX) stock?
You can purchase shares of BioNTech (NASDAQ:BNTX) through any online brokerage.
Who are BioNTech (BNTX) competitors?
Other companies in BioNTech’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for BioNTech (BNTX) stock?
BioNTech has a consensus price target of $152.40.
What is the current price for BioNTech (BNTX)?
The stock price for BioNTech (NASDAQ: BNTX) is $112.9 last updated September 23, 2024 at 5:18 AM EDT.
Does BioNTech (BNTX) pay a dividend?
There are no upcoming dividends for BioNTech.
When is BioNTech (NASDAQ:BNTX) reporting earnings?
BioNTech’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is BioNTech (BNTX) going to split?
There is no upcoming split for BioNTech.
What sector and industry does BioNTech (BNTX) operate in?
BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.